French study confirms that people with HIV born abroad are less likely to receive integrase inhibitors than those born in France

Data from across France shows that the choice of the antiretroviral regimen is influenced by the birth country of patients, without clear clinical, virological or immunological justification. These results confirm what was revealed by a recent study from a Paris hospital.

Dr Romain Palich from the Hôpital Pitié-Salpêtrière and his colleagues used the French national Dat’AIDS cohort to assess patients’ characteristics associated with the choice of antiretrovirals in people starting therapy in recent years. The team’s second objectives were to analyse the time to reach viral suppression and the time to treatment discontinuation.

Read the full story at Aidsmap.